Nationwide outcomes of 1000 robotic pancreatoduodenectomies across the four phases of the learning curve

Abstract Background Robotic pancreatoduodenectomy (RPD) is increasingly being implemented to enhance patient recovery, but it is unclear what happens to patient outcomes after the initial learning curve. The aim of this study was to evaluate the first 1000 consecutive RPD performed in the Netherland...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of surgery Jg. 112; H. 11
Hauptverfasser: Emmen, Anouk M L H, van den Broek, Bram L J, Hendriks, Tessa E, Busch, Olivier R, Bonsing, Bert A, Cappelle, Marie L, Coene, Peter-Paul L O, Festen, Sebastiaan, van der Harst, Erwin, de Hingh, Ignace H J T, van Laarhoven, Cees J H M, Lips, Daan J, Sprakel, Joost, Luyer, Misha D P, Mieog, J Sven D, van Santvoort, Hjalmar C, van der Schelling, George, Wijsman, Jan H, Patijn, Gijs A, de Wilde, Roeland F, Zwart, Maurice J W, Derksen, Wouter J M, Molenaar, I Quintus, Groot Koerkamp, Bas, Besselink, Marc G
Format: Journal Article
Sprache:Englisch
Veröffentlicht: UK Oxford University Press 06.11.2025
Schlagworte:
ISSN:0007-1323, 1365-2168, 1365-2168
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract Abstract Background Robotic pancreatoduodenectomy (RPD) is increasingly being implemented to enhance patient recovery, but it is unclear what happens to patient outcomes after the initial learning curve. The aim of this study was to evaluate the first 1000 consecutive RPD performed in the Netherlands. Methods A nationwide analysis of patients who underwent RPD in 13 centres (March 2016–August 2023) from the Dutch Pancreatic Cancer Audit was performed. Patients were grouped based on published learning curve cut-offs (phases 1–4): 1–15, 16–62, 63–84, and >84 RPD per centre respectively. Outcomes were compared between the four learning curve phases. Ideal Outcome rates were used to compare outcomes between centres. Results Overall, 1000 patients after RPD were included. The conversion rate was 10.1%, the rate of Clavien–Dindo complications of grade ≥III was 41.3%, the rate of postoperative pancreatic fistula of grade B/C was 24.4%, and the rate of in-hospital/30-day mortality was 3.9%. Of the patients, 71.1% had a high updated alternative fistula risk score. Improvements between the phases were found for five outcomes: median operating time (420, 360, 349, and 369 min respectively; P < 0.001), conversion rate (21.7%, 10.0%, 2.8%, and 7.5% respectively; P < 0.001), rate of delayed gastric emptying (DGE) of grade B/C (32.3%, 22.6%, 15.4%, and 20.2% respectively; P = 0.003), reoperation rate (9.9%, 11.3%, 9.8%, and 4.9% respectively; P = 0.026), and median duration of hospital stay (12, 11, 10, and 10 days respectively; P = 0.035). The rate of Clavien–Dindo complications of grade ≥III and the rate of in-hospital/30-day mortality remained stable. The Ideal Outcome rate (mean 47%) did not differ between centres. Conclusion Across four learning curve phases in a nationwide cohort, improvements were observed for operating time, conversion rate, rate of DGE of grade B/C, reoperation rate, and duration of hospital stay. A nationwide analysis of 1000 patients who underwent robotic pancreatoduodenectomy (RPD) in 13 centres (March 2016–August 2023) was performed. Outcomes were compared between patients in the four learning curve phases (1–15, 16–62, 63–84, and >84 RPD), determined per centre. Improvements were seen for median operative time, conversion rate, delayed gastric emptying grade B/C, reoperation rate, and median hospital stay. Between the four phases, the rate of Clavien–Dindo complications grade ≥III and the rate of in-hospital/30-day mortality remained stable. The nationwide rate of Ideal Outcome rate remained stable.
AbstractList Robotic pancreatoduodenectomy (RPD) is increasingly being implemented to enhance patient recovery, but it is unclear what happens to patient outcomes after the initial learning curve. The aim of this study was to evaluate the first 1000 consecutive RPD performed in the Netherlands. A nationwide analysis of patients who underwent RPD in 13 centres (March 2016-August 2023) from the Dutch Pancreatic Cancer Audit was performed. Patients were grouped based on published learning curve cut-offs (phases 1-4): 1-15, 16-62, 63-84, and >84 RPD per centre respectively. Outcomes were compared between the four learning curve phases. Ideal Outcome rates were used to compare outcomes between centres. Overall, 1000 patients after RPD were included. The conversion rate was 10.1%, the rate of Clavien-Dindo complications of grade ≥III was 41.3%, the rate of postoperative pancreatic fistula of grade B/C was 24.4%, and the rate of in-hospital/30-day mortality was 3.9%. Of the patients, 71.1% had a high updated alternative fistula risk score. Improvements between the phases were found for five outcomes: median operating time (420, 360, 349, and 369 min respectively; P < 0.001), conversion rate (21.7%, 10.0%, 2.8%, and 7.5% respectively; P < 0.001), rate of delayed gastric emptying (DGE) of grade B/C (32.3%, 22.6%, 15.4%, and 20.2% respectively; P = 0.003), reoperation rate (9.9%, 11.3%, 9.8%, and 4.9% respectively; P = 0.026), and median duration of hospital stay (12, 11, 10, and 10 days respectively; P = 0.035). The rate of Clavien-Dindo complications of grade ≥III and the rate of in-hospital/30-day mortality remained stable. The Ideal Outcome rate (mean 47%) did not differ between centres. Across four learning curve phases in a nationwide cohort, improvements were observed for operating time, conversion rate, rate of DGE of grade B/C, reoperation rate, and duration of hospital stay.
Abstract Background Robotic pancreatoduodenectomy (RPD) is increasingly being implemented to enhance patient recovery, but it is unclear what happens to patient outcomes after the initial learning curve. The aim of this study was to evaluate the first 1000 consecutive RPD performed in the Netherlands. Methods A nationwide analysis of patients who underwent RPD in 13 centres (March 2016–August 2023) from the Dutch Pancreatic Cancer Audit was performed. Patients were grouped based on published learning curve cut-offs (phases 1–4): 1–15, 16–62, 63–84, and >84 RPD per centre respectively. Outcomes were compared between the four learning curve phases. Ideal Outcome rates were used to compare outcomes between centres. Results Overall, 1000 patients after RPD were included. The conversion rate was 10.1%, the rate of Clavien–Dindo complications of grade ≥III was 41.3%, the rate of postoperative pancreatic fistula of grade B/C was 24.4%, and the rate of in-hospital/30-day mortality was 3.9%. Of the patients, 71.1% had a high updated alternative fistula risk score. Improvements between the phases were found for five outcomes: median operating time (420, 360, 349, and 369 min respectively; P < 0.001), conversion rate (21.7%, 10.0%, 2.8%, and 7.5% respectively; P < 0.001), rate of delayed gastric emptying (DGE) of grade B/C (32.3%, 22.6%, 15.4%, and 20.2% respectively; P = 0.003), reoperation rate (9.9%, 11.3%, 9.8%, and 4.9% respectively; P = 0.026), and median duration of hospital stay (12, 11, 10, and 10 days respectively; P = 0.035). The rate of Clavien–Dindo complications of grade ≥III and the rate of in-hospital/30-day mortality remained stable. The Ideal Outcome rate (mean 47%) did not differ between centres. Conclusion Across four learning curve phases in a nationwide cohort, improvements were observed for operating time, conversion rate, rate of DGE of grade B/C, reoperation rate, and duration of hospital stay. A nationwide analysis of 1000 patients who underwent robotic pancreatoduodenectomy (RPD) in 13 centres (March 2016–August 2023) was performed. Outcomes were compared between patients in the four learning curve phases (1–15, 16–62, 63–84, and >84 RPD), determined per centre. Improvements were seen for median operative time, conversion rate, delayed gastric emptying grade B/C, reoperation rate, and median hospital stay. Between the four phases, the rate of Clavien–Dindo complications grade ≥III and the rate of in-hospital/30-day mortality remained stable. The nationwide rate of Ideal Outcome rate remained stable.
Robotic pancreatoduodenectomy (RPD) is increasingly being implemented to enhance patient recovery, but it is unclear what happens to patient outcomes after the initial learning curve. The aim of this study was to evaluate the first 1000 consecutive RPD performed in the Netherlands.BACKGROUNDRobotic pancreatoduodenectomy (RPD) is increasingly being implemented to enhance patient recovery, but it is unclear what happens to patient outcomes after the initial learning curve. The aim of this study was to evaluate the first 1000 consecutive RPD performed in the Netherlands.A nationwide analysis of patients who underwent RPD in 13 centres (March 2016-August 2023) from the Dutch Pancreatic Cancer Audit was performed. Patients were grouped based on published learning curve cut-offs (phases 1-4): 1-15, 16-62, 63-84, and >84 RPD per centre respectively. Outcomes were compared between the four learning curve phases. Ideal Outcome rates were used to compare outcomes between centres.METHODSA nationwide analysis of patients who underwent RPD in 13 centres (March 2016-August 2023) from the Dutch Pancreatic Cancer Audit was performed. Patients were grouped based on published learning curve cut-offs (phases 1-4): 1-15, 16-62, 63-84, and >84 RPD per centre respectively. Outcomes were compared between the four learning curve phases. Ideal Outcome rates were used to compare outcomes between centres.Overall, 1000 patients after RPD were included. The conversion rate was 10.1%, the rate of Clavien-Dindo complications of grade ≥III was 41.3%, the rate of postoperative pancreatic fistula of grade B/C was 24.4%, and the rate of in-hospital/30-day mortality was 3.9%. Of the patients, 71.1% had a high updated alternative fistula risk score. Improvements between the phases were found for five outcomes: median operating time (420, 360, 349, and 369 min respectively; P < 0.001), conversion rate (21.7%, 10.0%, 2.8%, and 7.5% respectively; P < 0.001), rate of delayed gastric emptying (DGE) of grade B/C (32.3%, 22.6%, 15.4%, and 20.2% respectively; P = 0.003), reoperation rate (9.9%, 11.3%, 9.8%, and 4.9% respectively; P = 0.026), and median duration of hospital stay (12, 11, 10, and 10 days respectively; P = 0.035). The rate of Clavien-Dindo complications of grade ≥III and the rate of in-hospital/30-day mortality remained stable. The Ideal Outcome rate (mean 47%) did not differ between centres.RESULTSOverall, 1000 patients after RPD were included. The conversion rate was 10.1%, the rate of Clavien-Dindo complications of grade ≥III was 41.3%, the rate of postoperative pancreatic fistula of grade B/C was 24.4%, and the rate of in-hospital/30-day mortality was 3.9%. Of the patients, 71.1% had a high updated alternative fistula risk score. Improvements between the phases were found for five outcomes: median operating time (420, 360, 349, and 369 min respectively; P < 0.001), conversion rate (21.7%, 10.0%, 2.8%, and 7.5% respectively; P < 0.001), rate of delayed gastric emptying (DGE) of grade B/C (32.3%, 22.6%, 15.4%, and 20.2% respectively; P = 0.003), reoperation rate (9.9%, 11.3%, 9.8%, and 4.9% respectively; P = 0.026), and median duration of hospital stay (12, 11, 10, and 10 days respectively; P = 0.035). The rate of Clavien-Dindo complications of grade ≥III and the rate of in-hospital/30-day mortality remained stable. The Ideal Outcome rate (mean 47%) did not differ between centres.Across four learning curve phases in a nationwide cohort, improvements were observed for operating time, conversion rate, rate of DGE of grade B/C, reoperation rate, and duration of hospital stay.CONCLUSIONAcross four learning curve phases in a nationwide cohort, improvements were observed for operating time, conversion rate, rate of DGE of grade B/C, reoperation rate, and duration of hospital stay.
Author van den Broek, Bram L J
van der Schelling, George
Wijsman, Jan H
Patijn, Gijs A
Cappelle, Marie L
van Santvoort, Hjalmar C
Hendriks, Tessa E
Coene, Peter-Paul L O
Sprakel, Joost
Mieog, J Sven D
Molenaar, I Quintus
de Wilde, Roeland F
Festen, Sebastiaan
Derksen, Wouter J M
Emmen, Anouk M L H
van der Harst, Erwin
de Hingh, Ignace H J T
Besselink, Marc G
Bonsing, Bert A
Busch, Olivier R
van Laarhoven, Cees J H M
Groot Koerkamp, Bas
Lips, Daan J
Zwart, Maurice J W
Luyer, Misha D P
Author_xml – sequence: 1
  givenname: Anouk M L H
  surname: Emmen
  fullname: Emmen, Anouk M L H
– sequence: 2
  givenname: Bram L J
  surname: van den Broek
  fullname: van den Broek, Bram L J
– sequence: 3
  givenname: Tessa E
  orcidid: 0009-0007-7418-3056
  surname: Hendriks
  fullname: Hendriks, Tessa E
– sequence: 4
  givenname: Olivier R
  orcidid: 0000-0001-9605-6831
  surname: Busch
  fullname: Busch, Olivier R
– sequence: 5
  givenname: Bert A
  surname: Bonsing
  fullname: Bonsing, Bert A
– sequence: 6
  givenname: Marie L
  surname: Cappelle
  fullname: Cappelle, Marie L
– sequence: 7
  givenname: Peter-Paul L O
  surname: Coene
  fullname: Coene, Peter-Paul L O
– sequence: 8
  givenname: Sebastiaan
  surname: Festen
  fullname: Festen, Sebastiaan
– sequence: 9
  givenname: Erwin
  surname: van der Harst
  fullname: van der Harst, Erwin
– sequence: 10
  givenname: Ignace H J T
  orcidid: 0000-0003-3491-4268
  surname: de Hingh
  fullname: de Hingh, Ignace H J T
– sequence: 11
  givenname: Cees J H M
  surname: van Laarhoven
  fullname: van Laarhoven, Cees J H M
– sequence: 12
  givenname: Daan J
  surname: Lips
  fullname: Lips, Daan J
– sequence: 13
  givenname: Joost
  surname: Sprakel
  fullname: Sprakel, Joost
– sequence: 14
  givenname: Misha D P
  orcidid: 0000-0002-9483-1520
  surname: Luyer
  fullname: Luyer, Misha D P
– sequence: 15
  givenname: J Sven D
  orcidid: 0000-0002-3649-8504
  surname: Mieog
  fullname: Mieog, J Sven D
– sequence: 16
  givenname: Hjalmar C
  surname: van Santvoort
  fullname: van Santvoort, Hjalmar C
– sequence: 17
  givenname: George
  surname: van der Schelling
  fullname: van der Schelling, George
– sequence: 18
  givenname: Jan H
  surname: Wijsman
  fullname: Wijsman, Jan H
– sequence: 19
  givenname: Gijs A
  surname: Patijn
  fullname: Patijn, Gijs A
– sequence: 20
  givenname: Roeland F
  surname: de Wilde
  fullname: de Wilde, Roeland F
– sequence: 21
  givenname: Maurice J W
  surname: Zwart
  fullname: Zwart, Maurice J W
– sequence: 22
  givenname: Wouter J M
  surname: Derksen
  fullname: Derksen, Wouter J M
– sequence: 23
  givenname: I Quintus
  surname: Molenaar
  fullname: Molenaar, I Quintus
– sequence: 24
  givenname: Bas
  orcidid: 0000-0003-1917-6973
  surname: Groot Koerkamp
  fullname: Groot Koerkamp, Bas
– sequence: 25
  givenname: Marc G
  orcidid: 0000-0003-2650-9350
  surname: Besselink
  fullname: Besselink, Marc G
  email: m.g.besselink@amsterdamUMC.nl
BackLink https://www.ncbi.nlm.nih.gov/pubmed/41206577$$D View this record in MEDLINE/PubMed
BookMark eNo9kDtPwzAUhS0EghaY2JEnxBJ6r43jZESIl4RggTnykwY1drATEPx6UrUwXenc75zhm5PdEIMj5AThAqHmC_2eFz9BeYawQ2bIS1EwLKtdMgMAWSBn_IDMc34HQA6C7ZODS2RQCilnZPmkhjaGr9Y6GsfBxM5lGj3FqUtT1HFoDe1VMMmpIdoxWhecGWLXTpwyKeZMh6WjPo6J9kuVN_V1tHIqhTa8UTOmT3dE9rxaZXe8vYfk9fbm5fq-eHy-e7i-eiwiq3AouPSVR605SonGSMFq7UvGLErmhAYr6rLitkZtlVZWebz0UIEvBVQcTc0Pyflmt0_xY3R5aLo2G7daqeDimBvOJEAtBJcTerpFR9052_Sp7VT6bv7sTMDZBohj__9FaNbam0l7s9XOfwFuPHaC
ContentType Journal Article
Contributor Haen, Roel
Schreinemakers, Jennifer
Te Riele, Wouter
Karsten, Tom M
Huurman, Volkert
Kazemier, Geert
Brouwer-Hol, Lieke
Haberkorn, Brigitte C M
Hagendoorn, Jeroen
Tran, Khe
Vahrmeijer, Alexander
Daams, Freek
van Dam, Ronald
Liem, Mike
Jan Schipper, Robert
Stommel, Martijn
Contributor_xml – sequence: 1
  givenname: Freek
  surname: Daams
  fullname: Daams, Freek
– sequence: 2
  givenname: Geert
  surname: Kazemier
  fullname: Kazemier, Geert
– sequence: 3
  givenname: Khe
  surname: Tran
  fullname: Tran, Khe
– sequence: 4
  givenname: Roel
  surname: Haen
  fullname: Haen, Roel
– sequence: 5
  givenname: Alexander
  surname: Vahrmeijer
  fullname: Vahrmeijer, Alexander
– sequence: 6
  givenname: Volkert
  surname: Huurman
  fullname: Huurman, Volkert
– sequence: 7
  givenname: Robert
  surname: Jan Schipper
  fullname: Jan Schipper, Robert
– sequence: 8
  givenname: Ronald
  surname: van Dam
  fullname: van Dam, Ronald
– sequence: 9
  givenname: Jennifer
  surname: Schreinemakers
  fullname: Schreinemakers, Jennifer
– sequence: 10
  givenname: Lieke
  surname: Brouwer-Hol
  fullname: Brouwer-Hol, Lieke
– sequence: 11
  givenname: Brigitte C M
  surname: Haberkorn
  fullname: Haberkorn, Brigitte C M
– sequence: 12
  givenname: Mike
  surname: Liem
  fullname: Liem, Mike
– sequence: 13
  givenname: Wouter
  surname: Te Riele
  fullname: Te Riele, Wouter
– sequence: 14
  givenname: Jeroen
  surname: Hagendoorn
  fullname: Hagendoorn, Jeroen
– sequence: 15
  givenname: Martijn
  surname: Stommel
  fullname: Stommel, Martijn
– sequence: 16
  givenname: Tom M
  surname: Karsten
  fullname: Karsten, Tom M
Copyright The Author(s) 2025. Published by Oxford University Press on behalf of BJS Foundation Ltd. 2025
The Author(s) 2025. Published by Oxford University Press on behalf of BJS Foundation Ltd.
Copyright_xml – notice: The Author(s) 2025. Published by Oxford University Press on behalf of BJS Foundation Ltd. 2025
– notice: The Author(s) 2025. Published by Oxford University Press on behalf of BJS Foundation Ltd.
CorporateAuthor Members of the Dutch Institute for Clinical Auditing and the Dutch Pancreatic Cancer Group
CorporateAuthor_xml – name: Members of the Dutch Institute for Clinical Auditing and the Dutch Pancreatic Cancer Group
DBID TOX
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1093/bjs/znaf210
DatabaseName Oxford Journals Open Access Collection
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: TOX
  name: Oxford Journals Open Access Collection
  url: https://academic.oup.com/journals/
  sourceTypes: Publisher
– sequence: 3
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
EISSN 1365-2168
ExternalDocumentID 41206577
10.1093/bjs/znaf210
Genre Multicenter Study
Journal Article
GeographicLocations Netherlands
GeographicLocations_xml – name: Netherlands
GroupedDBID ---
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
1L6
1OC
1ZS
23N
31~
36B
3O-
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5RE
5VS
5WD
66C
6J9
6P2
702
7PT
8-0
8-1
8-3
8-4
8-5
8F7
8UM
930
A01
A03
AABZA
AACZT
AAESR
AAEVG
AAGQS
AAMMB
AANHP
AAONW
AAPGJ
AAPXW
AAQQT
AARHZ
AAUAY
AAVAP
AAWDT
AAYEP
AAZKR
ABCQN
ABCUV
ABDFA
ABEJV
ABEML
ABGNP
ABIJN
ABJNI
ABLJU
ABNHQ
ABOCM
ABPQP
ABPTD
ABPVW
ABQNK
ABVGC
ABWST
ABXVV
ACBWZ
ACFBH
ACFRR
ACGFO
ACGFS
ACMXC
ACPOU
ACRPL
ACSCC
ACUTJ
ACVCV
ACXQS
ACYHN
ACYXJ
ACZBC
ADBBV
ADEOM
ADIPN
ADIYS
ADIZJ
ADKYN
ADMGS
ADMTO
ADNBA
ADNMO
ADQBN
ADVEK
ADXAS
ADZMN
AEFGJ
AEGXH
AEIMD
AEMQT
AENEX
AFBPY
AFFNX
AFFQV
AFFZL
AFGKR
AFXAL
AFYAG
AFYLJ
AFZJQ
AGMDO
AGQPQ
AGQXC
AGUTN
AGXDD
AHGBF
AHMBA
AHMMS
AI.
AIAGR
AIDQK
AIDYY
AIURR
AJAOE
AJBYB
AJDVS
AJEEA
AJNCP
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALXQX
AMBMR
AMYDB
APJGH
AQDSO
ASPBG
ATGXG
ATUGU
AVNTJ
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BCRHZ
BDRZF
BEYMZ
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBS
EJD
EMOBN
EX3
F00
F01
F04
F5P
FEDTE
FLUFQ
FOEOM
FUBAC
G-S
G.N
GNP
GODZA
H.X
H13
HBH
HF~
HHY
HHZ
HVGLF
HZ~
IH2
IHE
IX1
J0M
J5H
JPC
JXSIZ
KBUDW
KOP
KQQ
KSI
KSN
L7B
LAW
LC2
LC3
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M65
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N4W
N9A
NF~
NNB
NOMLY
NU-
O66
O8X
O9-
OAUYM
OBFPC
OCZFY
OHH
OIG
OJZSN
OPAEJ
OVD
OWPYF
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RIWAO
RJQFR
ROL
ROX
RX1
RYL
SUPJJ
TEORI
TMA
TOX
UB1
V2E
V8K
V9Y
VH1
VVN
W8V
W99
WBKPD
WH7
WHWMO
WIB
WIH
WIJ
WIK
WJL
WOHZO
WQJ
WVDHM
WXI
X7M
XG1
XV2
YFH
YOC
YUY
ZGI
ZXP
ZY1
ZZTAW
~IA
~WT
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-o281t-37f8f1bb31771cc7529bf622d172e5b0d59683d91bdabadaf14f080f650831c93
IEDL.DBID TOX
ISICitedReferencesCount 0
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001611237500001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0007-1323
1365-2168
IngestDate Mon Nov 10 00:56:09 EST 2025
Fri Nov 14 01:40:50 EST 2025
Mon Dec 01 07:41:26 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
The Author(s) 2025. Published by Oxford University Press on behalf of BJS Foundation Ltd.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-o281t-37f8f1bb31771cc7529bf622d172e5b0d59683d91bdabadaf14f080f650831c93
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-3649-8504
0000-0001-9605-6831
0009-0007-7418-3056
0000-0002-9483-1520
0000-0003-1917-6973
0000-0003-3491-4268
0000-0003-2650-9350
OpenAccessLink https://dx.doi.org/10.1093/bjs/znaf210
PMID 41206577
PQID 3270095537
PQPubID 23479
ParticipantIDs proquest_miscellaneous_3270095537
pubmed_primary_41206577
oup_primary_10_1093_bjs_znaf210
PublicationCentury 2000
PublicationDate 2025-Nov-06
PublicationDateYYYYMMDD 2025-11-06
PublicationDate_xml – month: 11
  year: 2025
  text: 2025-Nov-06
  day: 06
PublicationDecade 2020
PublicationPlace UK
PublicationPlace_xml – name: UK
– name: England
PublicationTitle British journal of surgery
PublicationTitleAlternate Br J Surg
PublicationYear 2025
Publisher Oxford University Press
Publisher_xml – name: Oxford University Press
SSID ssj0013052
Score 2.4869142
Snippet Abstract Background Robotic pancreatoduodenectomy (RPD) is increasingly being implemented to enhance patient recovery, but it is unclear what happens to...
Robotic pancreatoduodenectomy (RPD) is increasingly being implemented to enhance patient recovery, but it is unclear what happens to patient outcomes after the...
SourceID proquest
pubmed
oup
SourceType Aggregation Database
Index Database
Publisher
SubjectTerms Adult
Aged
Aged, 80 and over
Female
Humans
Learning Curve
Length of Stay - statistics & numerical data
Male
Middle Aged
Netherlands - epidemiology
Operative Time
Pancreatic Neoplasms - surgery
Pancreaticoduodenectomy - adverse effects
Pancreaticoduodenectomy - education
Pancreaticoduodenectomy - methods
Pancreaticoduodenectomy - statistics & numerical data
Postoperative Complications - epidemiology
Postoperative Complications - etiology
Retrospective Studies
Robotic Surgical Procedures - adverse effects
Robotic Surgical Procedures - education
Robotic Surgical Procedures - statistics & numerical data
Treatment Outcome
Title Nationwide outcomes of 1000 robotic pancreatoduodenectomies across the four phases of the learning curve
URI https://www.ncbi.nlm.nih.gov/pubmed/41206577
https://www.proquest.com/docview/3270095537
Volume 112
WOSCitedRecordID wos001611237500001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVWIB
  databaseName: Wiley Online Library - Journals
  customDbUrl:
  eissn: 1365-2168
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0013052
  issn: 0007-1323
  databaseCode: DRFUL
  dateStart: 19980101
  isFulltext: true
  titleUrlDefault: https://onlinelibrary.wiley.com
  providerName: Wiley-Blackwell
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1LS8QwEA6-Dl584Gt9rBG8FpumaZKjqIsHWUVW2FvJ0wfYLtutgr_eSVsVVNAeQzOEyTTzZb7ODELHzAkmHGURTXUapZzaSDOnIqssj72RhinTNJvgw6EYj-VN94Ns9QuFL-mJfqpO3grlkyaTijARzHl0Pf4iC2LWFgUP9Q5pQrs0vG9zv2Ww_QCSjUMZrP53KWtopYOM-LTd43U054oN9NAWtH59tA6X9QzsxlW49DgE0vG01CW8jOFLb6_Vti7hfAkB-me4GWPV-EYM2A97kI4nD-DLmulhqGskcY9NPX1xm-hucDE6u4y6rglRmQgygxPDC0-0BmDAiTGcJVL7LEksQBXHdGyZzAS1kmirtLLKk9QDbPQBqlFiJN1CC0VZuB2EpSEx1XGo_0NTr6hmsYVHMM-Zz1TWQ4eg0nzS1sXIWz6b5qClvNNSDx19qDsHuw1khCpcWVc5DYy3ZIzyHtpu9-FTUEoSQEac7_4pfw8tJ6Ehb4jzZvtoYTat3QFaMi-zx2raR_N8LPpo8fx2cHfVb4zmHfEpvlM
linkProvider Oxford University Press
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Nationwide+outcomes+of+1000+robotic+pancreatoduodenectomies+across+the+four+phases+of+the+learning+curve&rft.jtitle=British+journal+of+surgery&rft.au=Emmen%2C+Anouk+M+L+H&rft.au=van+den+Broek%2C+Bram+L+J&rft.au=Hendriks%2C+Tessa+E&rft.au=Busch%2C+Olivier+R&rft.date=2025-11-06&rft.issn=1365-2168&rft.eissn=1365-2168&rft.volume=112&rft.issue=11&rft_id=info:doi/10.1093%2Fbjs%2Fznaf210&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0007-1323&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0007-1323&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0007-1323&client=summon